Accolate and Vision blurred - a phase IV clinical study of FDA data

Summary:

Vision blurred is reported as a side effect among people who take Accolate (zafirlukast), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Ambien, and have High blood pressure.

The phase IV clinical study analyzes which people have Vision blurred when taking Accolate. It is created by eHealthMe based on reports of 4,145 people who have side effects when taking Accolate from the FDA, and is updated regularly.

What is Accolate?

Accolate has active ingredients of zafirlukast. It is often used in asthma. eHealthMe is studying from 4,220 Accolate users. Check the latest studies of Accolate.

What is Vision blurred?

Vision blurred is found to be associated with 2,494 drugs and 2,969 conditions by eHealthMe. Check the latest studies of Vision blurred.

On Aug, 08, 2026

4,145 people reported to have side effects when taking Accolate.
Among them, 35 people (0.84%) have Vision blurred.

Among these 35 people:

How long have people been on Accolate when they have Vision blurred? *

What is the gender of people who have Vision blurred when taking Accolate? *

female: 69.7 %
male: 30.3 %

What is the age of people who have Vision blurred when taking Accolate? *

What are other drugs people take besides Accolate? *

What are other side effects people have besides Vision blurred? *

Nausea (feeling of having an urge to vomit): 10 people, 28.57%
Tremor (trembling or shaking movements in one or more parts of your body): 9 people, 25.71%
Dyspnea (difficult or laboured breathing): 9 people, 25.71%
Headache (pain in head): 9 people, 25.71%
Drug Ineffective: 7 people, 20.00%
Hypoaesthesia (reduced sense of touch or sensation): 6 people, 17.14%
Insomnia (sleeplessness): 6 people, 17.14%
Mood Swings (an extreme or rapid change in mood): 5 people, 14.29%
Malaise (a feeling of general discomfort or uneasiness): 5 people, 14.29%
Dizziness: 5 people, 14.29%

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 17.14%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 11.43%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 11.43%
Pain: 3 people, 8.57%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 3 people, 8.57%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.57%
Quit Smoking: 2 people, 5.71%
Nausea (feeling of having an urge to vomit): 2 people, 5.71%
Stress And Anxiety: 1 person, 2.86%
Gastric Ulcer (stomach ulcer): 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Accolate and have Vision blurred?

- Check whether Vision blurred is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Accolate:

Accolate (4,220 reports)

Vision blurred treatments and more:

Vision blurred (154,118 reports)

Browse all side effects of Accolate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vision blurred:

Vision blurred (2,494 drugs)

Browse all the conditions that are associated with Vision blurred:

Vision blurred (2,969 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on zafirlukast (the active ingredients of Accolate) and Accolate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.